Ratanachat Racharaks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ratanachat Racharaks has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Egon Anderson Ozer
Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
2 shared publications - Erica Marie Hartmann
Northwestern University
2 shared publications - Stefanie Huttelmaier
Department of Civil and Environmental Engineering, Northwestern University, Evanston, Illinois, USA
2 shared publications - Thomas Ipoutcha
Department of infectious disease, Imperial College London, London, UK
2 shared publications - Barry J. Allred
USDA/ARS Soil Drainage Research Unit, 590 Woody Hayes Drive, Columbus, OH 43210, USA
1 shared publication Cole J Wilson
Department of Civil and Environmental Engineering, Northwestern University, Evanston, Illinois, USA
1 shared publication
Latest Publications
- Open Access
- 5 March 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (3) , e0289723
A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages
The rise in the frequency of antibiotic resistance has made bacterial infections, specifically Pseudomonas aeruginosa , a cause for greater concern. Phage therapy is a promising solution that uses naturally isolated phages to treat bacterial infections. Ecological limitations, which stipulate a discrete host range and the inevitable evolution of resistance, may be overcome through a better understanding of phage biology and the utilization of engineered phages. In this study, we developed a synthetic biology approach to construct tailed phages that naturally target clinically relevant strains of Pseudomonas aeruginosa . As proof of concept, we successfully cloned and assembled the JG024 and DMS3 phage genomes in yeast using transformation-associated recombination cloning and rebooted these two phage genomes in two different strains of P. aeruginosa . We identified factors that affected phage reboot efficiency like the phage species or the presence of antiviral defense systems in the bacterial strain. We have successfully extended this method to two other phage species and observed that the method enables the reboot of phages that are naturally unable to infect the strain used for reboot. This research represents a critical step toward the construction of clinically relevant, engineered P. aeruginosa phages. IMPORTANCE: Pseudomonas aeruginosa is a bacterium responsible for severe infections and a common major complication in cystic fibrosis. The use of antibiotics to treat bacterial infections has become increasingly difficult as antibiotic resistance has become more prevalent. Phage therapy is an alternative solution that is already being used in some European countries, but its use is limited by the narrow host range due to the phage receptor specificity, the presence of antiviral defense systems in the bacterial strain, and the possible emergence of phage resistance. In this study, we demonstrate the use of a synthetic biology approach to construct and reboot clinically relevant P. aeruginosa tailed phages. This method enables a significant expansion of possibilities through the construction of engineered phages for therapy applications.
- 5 March 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (3) , e0289723
Open AccessA synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages
The rise in the frequency of antibiotic resistance has made bacterial infections, specifically Pseudomonas aeruginosa , a cause for greater concern. Phage therapy is a promising solution that uses naturally isolated phages to treat bacterial infections. Ecological limitations, which stipulate a discrete host range and the inevitable evolution of resistance, may be overcome through a better understanding of phage biology and the utilization of engineered phages. In this study, we developed a synthetic biology approach to construct tailed phages that naturally target clinically relevant strains of Pseudomonas aeruginosa . As proof of concept, we successfully cloned and assembled the JG024 and DMS3 phage genomes in yeast using transformation-associated recombination cloning and rebooted these two phage genomes in two different strains of P. aeruginosa . We identified factors that affected phage reboot efficiency like the phage species or the presence of antiviral defense systems in the bacterial strain. We have successfully extended this method to two other phage species and observed that the method enables the reboot of phages that are naturally unable to infect the strain used for reboot. This research represents a critical step toward the construction of clinically relevant, engineered P. aeruginosa phages. IMPORTANCE: Pseudomonas aeruginosa is a bacterium responsible for severe infections and a common major complication in cystic fibrosis. The use of antibiotics to treat bacterial infections has become increasingly difficult as antibiotic resistance has become more prevalent. Phage therapy is an alternative solution that is already being used in some European countries, but its use is limited by the narrow host range due to the phage receptor specificity, the presence of antiviral defense systems in the bacterial strain, and the possible emergence of phage resistance. In this study, we demonstrate the use of a synthetic biology approach to construct and reboot clinically relevant P. aeruginosa tailed phages. This method enables a significant expansion of possibilities through the construction of engineered phages for therapy applications.
- Open Access
A synthetic biology approach to assemble and reboot clinically-relevant Pseudomonas aeruginosa tailed phages
The rise in frequency of antibiotic resistance has made bacterial infections, specifically Pseudomonas aeruginosa , a cause for greater concern. Phage therapy is a promising solution that uses naturally isolated phages to treat bacterial infections. Ecological limitations, which stipulate a discrete host range and the inevitable evolution of resistance, may be overcome through a better understanding of phage biology and the utilization of engineered phages. In this study, we developed a synthetic biology approach to construct tailed phages that naturally target clinically-relevant strains of Pseudomonas aeruginosa . As proof of concept, we successfully cloned and assembled the JG024 and DMS3 phage genomes in yeast using transformation-associated recombination (TAR) cloning and rebooted these two phage genomes in two different strains of P. aeruginosa . We identified factors that affected phage reboot efficiency like the phage species or the presence of antiviral defense systems in the bacterial strain. We have successfully extended this method to two other phage species and observed that the method enables the reboot of phages that are naturally unable to infect the strain used for reboot. This research represents a critical step towards the construction of clinically-relevant, engineered P. aeruginosa phages. Importance: Pseudomonas aeruginosa is a bacterium responsible for severe infections and a common major complication in cystic fibrosis. The use of antibiotics to treat bacterial infections has become increasingly difficult as antibiotic resistance has become more prevalent. Phage therapy is an alternative solution that is already being used in some European countries, but its use is limited by narrow host range due to the phage receptor specificity, the presence of antiviral defense systems in the bacterial strain, and the possible emergence of phage resistance. In this study, we demonstrate the use of a synthetic biology approach to construct and reboot clinically-relevant P. aeruginosa tailed phages. This method enables a significant expansion of possibilities through the construction of engineered phages for therapy applications.
Open AccessA synthetic biology approach to assemble and reboot clinically-relevant Pseudomonas aeruginosa tailed phages
The rise in frequency of antibiotic resistance has made bacterial infections, specifically Pseudomonas aeruginosa , a cause for greater concern. Phage therapy is a promising solution that uses naturally isolated phages to treat bacterial infections. Ecological limitations, which stipulate a discrete host range and the inevitable evolution of resistance, may be overcome through a better understanding of phage biology and the utilization of engineered phages. In this study, we developed a synthetic biology approach to construct tailed phages that naturally target clinically-relevant strains of Pseudomonas aeruginosa . As proof of concept, we successfully cloned and assembled the JG024 and DMS3 phage genomes in yeast using transformation-associated recombination (TAR) cloning and rebooted these two phage genomes in two different strains of P. aeruginosa . We identified factors that affected phage reboot efficiency like the phage species or the presence of antiviral defense systems in the bacterial strain. We have successfully extended this method to two other phage species and observed that the method enables the reboot of phages that are naturally unable to infect the strain used for reboot. This research represents a critical step towards the construction of clinically-relevant, engineered P. aeruginosa phages. Importance: Pseudomonas aeruginosa is a bacterium responsible for severe infections and a common major complication in cystic fibrosis. The use of antibiotics to treat bacterial infections has become increasingly difficult as antibiotic resistance has become more prevalent. Phage therapy is an alternative solution that is already being used in some European countries, but its use is limited by narrow host range due to the phage receptor specificity, the presence of antiviral defense systems in the bacterial strain, and the possible emergence of phage resistance. In this study, we demonstrate the use of a synthetic biology approach to construct and reboot clinically-relevant P. aeruginosa tailed phages. This method enables a significant expansion of possibilities through the construction of engineered phages for therapy applications.
- 23 January 2019
- Published by Springer Nature in Journal of Applied Phycology
- Vol. 31 (4) , 2267-2276
Cryopreservation of Synechococcus elongatus UTEX 2973
- 23 January 2019
- Published by Springer Nature in Journal of Applied Phycology
- Vol. 31 (4) , 2267-2276
Cryopreservation of Synechococcus elongatus UTEX 2973
- 1 September 2015
- Published by Elsevier in Bioresource Technology
- Vol. 191, 146-156
Cultivation of marine microalgae using shale gas flowback water and anaerobic digestion effluent as the cultivation medium
- 1 September 2015
- Published by Elsevier in Bioresource Technology
- Vol. 191, 146-156
Cultivation of marine microalgae using shale gas flowback water and anaerobic digestion effluent as the cultivation medium
- 1 September 2014
- Published by Wiley in Water Environment Research
- Vol. 86 (9) , 852-862
Laboratory Comparison of Four Iron‐Based Filter Materials for Drainage Water Phosphate Treatment
: A laboratory investigation evaluated phosphate (PO43–) drainage water treatment capabilities of four iron‐based filter materials. The iron‐based filter materials tested were zero‐valent iron (ZVI), porous iron composite (PIC), sulfur modified iron (SMI), and iron oxide/hydroxide (IOH). Only filter material retained on a 60‐mesh sieve (>0.25 mm) was used for evaluation. The laboratory investigation included saturated falling‐head hydraulic conductivity tests, contaminant removal or desorption/dissolution batch tests, and low‐to‐high flow rate saturated solute transport column tests. Each of the four iron‐based filter materials have sufficient water flow capacity as indicated by saturated hydraulic conductivity values that in most cases were greater than 1 × 10−2 cm/s. For the 1, 10, and 100 ppm PO43–‐P contaminant removal batch tests, each of the four iron‐based filter materials removed at least 95% of the PO43–‐P originally present. However, for the 1000 ppm PO43–‐P contaminant removal batch tests, IOH by far exhibited the greatest removal effectiveness (99% PO43–‐P removal), followed by SMI (72% PO43–‐P removal), then ZVI (62% PO43–‐P removal), and finally PIC (15% PO43–‐P removal). The desorption/dissolution batch test results, especially with respect to SMI and IOH, indicate that once PO43– is adsorbed/precipitated onto surfaces of iron‐based filter material particles, this PO43– becomes fixed and is then not readily desorbed/dissolved back into solution. The results from the column tests showed that regardless of low or high flow rate (contact time ranged from a few hours to a few minutes) and PO43– concentration (1 ppm or 10 ppm PO43–‐P), PIC, SMI, and IOH reduced PO43–‐P concentrations to below detection limits, while ZVI removed at least 90% of the influent PO43–‐P. Consequently, these laboratory results indicate that the ZVI, PIC, SMI, and IOH filter materials all exhibit promise for phosphate drainage water treatment.
- 1 September 2014
- Published by Wiley in Water Environment Research
- Vol. 86 (9) , 852-862
Laboratory Comparison of Four Iron‐Based Filter Materials for Drainage Water Phosphate Treatment
: A laboratory investigation evaluated phosphate (PO43–) drainage water treatment capabilities of four iron‐based filter materials. The iron‐based filter materials tested were zero‐valent iron (ZVI), porous iron composite (PIC), sulfur modified iron (SMI), and iron oxide/hydroxide (IOH). Only filter material retained on a 60‐mesh sieve (>0.25 mm) was used for evaluation. The laboratory investigation included saturated falling‐head hydraulic conductivity tests, contaminant removal or desorption/dissolution batch tests, and low‐to‐high flow rate saturated solute transport column tests. Each of the four iron‐based filter materials have sufficient water flow capacity as indicated by saturated hydraulic conductivity values that in most cases were greater than 1 × 10−2 cm/s. For the 1, 10, and 100 ppm PO43–‐P contaminant removal batch tests, each of the four iron‐based filter materials removed at least 95% of the PO43–‐P originally present. However, for the 1000 ppm PO43–‐P contaminant removal batch tests, IOH by far exhibited the greatest removal effectiveness (99% PO43–‐P removal), followed by SMI (72% PO43–‐P removal), then ZVI (62% PO43–‐P removal), and finally PIC (15% PO43–‐P removal). The desorption/dissolution batch test results, especially with respect to SMI and IOH, indicate that once PO43– is adsorbed/precipitated onto surfaces of iron‐based filter material particles, this PO43– becomes fixed and is then not readily desorbed/dissolved back into solution. The results from the column tests showed that regardless of low or high flow rate (contact time ranged from a few hours to a few minutes) and PO43– concentration (1 ppm or 10 ppm PO43–‐P), PIC, SMI, and IOH reduced PO43–‐P concentrations to below detection limits, while ZVI removed at least 90% of the influent PO43–‐P. Consequently, these laboratory results indicate that the ZVI, PIC, SMI, and IOH filter materials all exhibit promise for phosphate drainage water treatment.
- 1 August 2013
- Published by Elsevier in Applied Energy
- Vol. 108, 486-492
Cultivation of Nannochloropsis salina using anaerobic digestion effluent as a nutrient source for biofuel production
- 1 August 2013
- Published by Elsevier in Applied Energy
- Vol. 108, 486-492
Cultivation of Nannochloropsis salina using anaerobic digestion effluent as a nutrient source for biofuel production